Form 4: Sarissa Capital Management Sells Over 1.5 Million Shares of Innoviva, Inc.

Sarissa Capital Management, led by Alexander J. Denner, sold 1,518,295 shares of Innoviva, Inc. (INVA) between March 4 and March 6, 2025.

Summary

• Alexander J. Denner and Sarissa Capital Management LP reported the sale of Innoviva, Inc. (INVA) shares.
• The sales occurred over three days, from March 4 to March 6, 2025.
• On March 4, 2025, 151,175 shares were sold at a weighted average price of $17.6291 per share.
• On March 5, 2025, 270,374 shares were sold at a weighted average price of $17.6279 per share.
• On March 6, 2025, 1,196,746 shares were sold at a weighted average price of $17.5177 per share.
• Following these transactions, Sarissa Capital Management still indirectly beneficially owns 5,658,705 shares.
• Sarissa Capital Management LP is the investment advisor to several Sarissa Funds and may be deemed to beneficially own the shares.
• Alexander J. Denner, as Chief Investment Officer and ultimate general partner of Sarissa Capital, may also be deemed to beneficially own the shares.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. A major shareholder selling a significant portion of their shares can be interpreted negatively by the market, although the remaining stake is still substantial.

Negatives

• Sarissa Capital Management, a significant shareholder, has reduced its stake in Innoviva, Inc.

Risks

• Continued selling pressure from Sarissa Capital could negatively impact Innoviva's stock price.

Industry Context

Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their trading activities. These filings are closely watched by investors for insights into the sentiment and intentions of key players.

Stakeholder Impact

• Shareholders may react to the news of Sarissa Capital's share sales.
• The stock price of Innoviva could be affected by these transactions.

Key Dates